Infinimax Womens Enhancer
Natural health product licensed in Canada
- Licence holder
- After Dark Labs, LLC
- NPN or DIN-HM
- 80073739
- Status
- Inactive licence
- Licence date
- 14 November 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ptychopetalum olacoides Source : Écorce âgée Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Pueraria candollei Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 60 milligramme | 15 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 333.33 milligramme | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Turnera diffusa Source : Feuille | 50 milligramme | Not calculated |
| Rhodiola rosea Source : Racine | 50 milligramme | Not calculated |
| Vitex agnus-castus Source : Fruit | 25 milligramme | Not calculated |
| Hebanthe eriantha Source : Racine | 25 milligramme | Not calculated |
| Verbena hastata Source : Feuille et tige Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 60 milligramme | 15 milligramme | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 740 milligramme Potency : 45 % Steroidal Saponins | 37 milligramme | Not calculated |
| Asparagus racemosus Source : Racine Extract : Matériel brut sec Extraction ratio : 8.5:1 Dry plant equivalent : 127.5 milligramme Potency : 20 % Saponins | 15 milligramme | Not calculated |
| Salvia officinalis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 60 milligramme | 15 milligramme | Not calculated |
| Smilax aristolochiifolia Source : Racine | 15 milligramme | Not calculated |
Non-medicinal ingredients
Eau, Cellulose, Maltodextrine, Amidon alimentaire, modifié, Stéarate de magnésium, Silice pyrogénée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Vitex is used in Herbal Medicine to help relieve premenstrual symptoms. Vitex is used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Vitex is used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Maca provides antioxidants. L-Arginine is a non-essential amino acid that is involved in protein synthesis. L-Arginine supports production of nitric oxide, a molecule involved in vasodilation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you suffer from high blood pressure; a hormone-sensitive condition; a renal/kidney disease; hypertension; are following a low protein diet; if you suffer from a cardiovascular disease and are attempting an increase in physical activity or if you are taking antidepressants, steroids, medication for cardiovascular diseases, erectile dysfunction, blood thinners, or hormone-containing medications such as progesterone preparations, oral contraceptives (birth control pills) or hormone replacement therapy. Consult a health care practitioner if your cardiovascular condition worsens, or if other symptoms persist or worsen.
- Contre-indications
Do not use if you are pregnant, breastfeeding, or have a seizure disorder (e.g. epilepsy), bipolar or bipolar spectrum disorder. Do not use if you have had a heart attack/myocardial infarction.
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea or nausea). Hypersensitivity/allergy, irritability, and insomnia has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80073739
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.